CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
513.89 -0.74(-0.14%) NAV as on 13 Jun 2025
4.61 % 1 M
13.72 % 1 Y
25.49 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.80

As on 31 May, 2025
age-icon Age :

21 yrs 0 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,352.16 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.86

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2025
Others 1.42 %
Equity 98.58 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.57 %
Divi's Laboratories Ltd.9.49 %
Lupin Ltd.5.82 %
Cipla Ltd.5.62 %
Dr. Reddy's Laboratories Ltd.5.49 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs79.45
Hospital & Healthcare Services18.26
Business Support0.87
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)250.18290.14270.59428.87481.27
Net Assets(Rs Crores) (as on 31-Mar-2025) 4260.99 4931.89 4304.46 7125.28 8080.97
Scheme Returns(%)(Absolute)77.3614.83-6.8558.2410.94
B'mark Returns(%)(Absolute)NANANANANA
Category Rank32/7543/7565/7617/9030/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity513.89-0.74(-0.14%)NAV As on 13 Jun, 202505-Jun-2004Inception Date8,352.16AUM In Cr.13.72%1Y25.49%3Y21.99%5Y20.60%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.37-0.05(-0.13%)NAV As on 13 Jun, 202513-Jul-2018Inception Date5,507.52AUM In Cr.21.93%1Y29.75%3Y25.03%5Y21.89%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity426.54-0.14(-0.03%)NAV As on 13 Jun, 202514-Jul-1999Inception Date3,689.28AUM In Cr.19.31%1Y29.09%3Y24.17%5Y16.31%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.90-0.08(-0.27%)NAV As on 13 Jun, 202528-Dec-2015Inception Date1,231.67AUM In Cr.13.65%1Y24.87%3Y21.50%5Y12.27%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors